Search research articles
Contact Us
Filters
Showing results (161-170 of 250) with videos related to
Page
of 25
Sort By:
Cancer Chemotherapy and Pharmacology
|
June 10, 2017
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
Bum Jun Kim, Jaewon Hyung, Changhoon Yoo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 26, 2020
Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events
Changhoon Yoo, Seonggyu Byeon, Yeonghak Bang, et al.
The British Journal of Surgery
|
August 11, 2021
Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival
Woohyung Lee, Minyoung Oh, Jae Seung Kim, et al.
Gastroenterology
|
August 27, 2018
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8<sup>+</sup> T Cells and Features of Hepatocellular Carcinoma
Hyung-Don Kim, Gi-Won Song, Seongyeol Park, et al.
Anticancer Research
|
March 28, 2023
Identification of Atezolizumab Plus Bevacizumab Prognostic Index <i>via</i> Recursive Partitioning Analysis in HCC: The ABE Index
Mara Persano, Margherita Rimini, Toshifumi Tada, et al.
Journal of Cancer Research and Clinical Oncology
|
March 27, 2023
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular-cholangiocarcinoma
Yoon Jung Jang, Eo Jin Kim, Hyung-Don Kim, et al.
Targeted Oncology
|
December 28, 2025
Claudin-18.2 and Trop-2 as Emerging Biomarkers in Biliary Tract Cancers: Expression Analysis and Therapeutic Potential
Yeokyeong Shin, Jinho Shin, Hyehyun Jeong, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2025
Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer
Hyung-Don Kim, Seyoung Jung, Yeong Hak Bang, et al.
Hepatology (Baltimore, Md.)
|
June 14, 2024
Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial
Do-Youn Oh, Masafumi Ikeda, Choong-Kun Lee, et al.
Cancer Chemotherapy and Pharmacology
|
October 29, 2013
Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)
Yoon-Koo Kang, Jeong Hwan Yook, Heung-Moon Chang, et al.
Page
of 25
Search research articles
Search
Showing results (161-170 of 250) with videos related to
Sort By:
Page
of 25
Cancer Chemotherapy and Pharmacology
|
June 10, 2017
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
Bum Jun Kim, Jaewon Hyung, Changhoon Yoo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 26, 2020
Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events
Changhoon Yoo, Seonggyu Byeon, Yeonghak Bang, et al.
The British Journal of Surgery
|
August 11, 2021
Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival
Woohyung Lee, Minyoung Oh, Jae Seung Kim, et al.
Gastroenterology
|
August 27, 2018
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8<sup>+</sup> T Cells and Features of Hepatocellular Carcinoma
Hyung-Don Kim, Gi-Won Song, Seongyeol Park, et al.
Anticancer Research
|
March 28, 2023
Identification of Atezolizumab Plus Bevacizumab Prognostic Index <i>via</i> Recursive Partitioning Analysis in HCC: The ABE Index
Mara Persano, Margherita Rimini, Toshifumi Tada, et al.
Journal of Cancer Research and Clinical Oncology
|
March 27, 2023
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular-cholangiocarcinoma
Yoon Jung Jang, Eo Jin Kim, Hyung-Don Kim, et al.
Targeted Oncology
|
December 28, 2025
Claudin-18.2 and Trop-2 as Emerging Biomarkers in Biliary Tract Cancers: Expression Analysis and Therapeutic Potential
Yeokyeong Shin, Jinho Shin, Hyehyun Jeong, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2025
Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer
Hyung-Don Kim, Seyoung Jung, Yeong Hak Bang, et al.
Hepatology (Baltimore, Md.)
|
June 14, 2024
Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial
Do-Youn Oh, Masafumi Ikeda, Choong-Kun Lee, et al.
Cancer Chemotherapy and Pharmacology
|
October 29, 2013
Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)
Yoon-Koo Kang, Jeong Hwan Yook, Heung-Moon Chang, et al.
Page
of 25